Advanced (3D/4D) Visualizations Systems Market Driven by Numerous Cancer Cases

A recently added report by TMR Research, titled, “Advanced (3D/4D) Visualization Systems Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025,” offers important information on the size of the market, the prevalent competitive dynamics in it, a qualitative analysis of growth drivers and restraints shaping its contours, and its prospects going forward.
The market for advanced (3D/4D) visualization systems, which aid in diagnosing and treating different cardiology, oncology, and neurology cases, is seeing swift growth due to the increasing instances of cancer globally and also due to the rise in different cardiovascular diseases that often result in death. Besides, the legal requirements set by the U.S. Food and Drug Administration (FDA) pertaining to the maintenance of picture archiving and communications system (PACS) records has generated a need to digitize patient data. This is slated to have a positive impact on the uptake of advanced (3D/4D) visualization systems too.
Further, advanced (3D/4D) visualization systems serve to bring down costs through effective diagnosis. This will likely generate greater opportunities in the market in the upcoming years.
One factor posing a roadblock to the global market for advanced (3D/4D) visualization systems is the steep cost of equipment. However, the increasing instances of chronic diseases along with the development of novel software and services will help to overcome the deterrent. Besides, continued improvement in healthcare infrastructure, progress in computer technology, and demand for improved imaging technology are also pushing up demand in the market.
From a geographical standpoint, North America at present accounts for maximum demand in the advanced (3D/4D) visualization systems market due to a solid healthcare infrastructure, awareness among the patients, and quick uptake of cutting-edge technology. The market in Europe is also predicted to demonstrate good growth on the back of rising healthcare expenditure. Further, Asia Pacific, powered by emerging economies of China, India, and Malaysia, will see good growth on account of a massive under-served patient population and the thrust on research and development programs pertaining to healthcare infrastructure. However, high upfront costs involved in installing the systems are posing a hindrance to the market in the region.
In order to comprehend the competition prevailing in the global market for advanced (3D/4D) visualization systems, the report profiles prominent companies such as Carestream Health, Inc., QI Imaging, LLC, Fujifilm Holding America Corporation, CONMED Corporation, Toshiba Medical Systems Corporation, GE Healthcare, Philips Healthcare, Intelerad Medical Systems Inc., Siemens Healthcare, Terarecon, Inc., Visage Imaging, and Visualization Sciences Group. It studies their revenues, market shares, key strategies, and possible future trajectory in details.



Popular posts from this blog

EMA Recommends Extension of Indications for Ramucirumab

Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Is Indian pharma ready to tap the European market?